Storyline · business · 2 reports from 1 newsroom

Moderna cancer vaccine data leak

First reported Oct 21, 11:00 AM ET · Latest Oct 22, 2:35 PM ET · Explainer updated Oct 22, 3:02 PM ET

▶ Hear this story · Orion

Why it was in the Relay Update: Reported independently by 2 newsrooms, 5 hours old when it aired, picked for the Business & Tech desk.

Where things stand

MarketWatch reports that Moderna’s stock fell after a reported leak of data for its experimental cancer vaccine, which it and Merck plan to present at a medical conference this weekend. The previous MarketWatch story said the full Phase 3 results were set to be revealed at that same conference.

What changed

The newest report adds that the data have been leaked, whereas earlier coverage only mentioned the upcoming public release of the Phase 3 results.

Questions we’re following

  • The content of the leaked information and how it compares to the complete trial results remain unclear, as does the potential impact on the vaccine’s efficacy and safety profile. Open

Background

The vaccine is in Phase 3 trials, the final stage of testing before regulatory approval, and is being co‑developed by Moderna and Merck. A medical conference is the venue where companies often share detailed trial outcomes with doctors and investors.

What to watch

The conference where the full Phase 3 data are to be presented is expected this weekend; no specific date is given.

Timeline of reporting

  1. Moderna’s stock tumbles after reported leak of data for cancer vaccine — MarketWatch

    Moderna and Merck are expected to share the Phase 3 data for their experimental cancer vaccine this weekend at a medical conference.

  2. Moderna is about to release the trial results for its cancer vaccine. A lot is riding on this data. — MarketWatch

    Moderna is one of the hottest stocks of the year because of its custom cancer treatment. Full Phase 3 data are set to be revealed this weekend.

How this works: stories from different newsrooms are grouped by topic, then AI writes the explainer using only those reports. It may miss context the reports don't include.